Aesthetics Combination Therapy market Detailed Analysis With Alma Lasers Ltd., Lumenis Ltd., Cynosure Inc., Valeant Pharmaceutical International, Inc., Galderma S.A., Anika Therapeutics, Inc., Speciality European Pharma, Merz Pharma GmbH & Co. KGaA, Cuter

The global aesthetics combination therapy market was valued at US$ 1.97 Bn in 2016, and a new report from Persistence Market Research anticipates it to reach US$ 3.69 Bn by 2024. The market is projected to grow at a CAGR of 8.1% during the period 2016-2024.

North America and Europe continue to be the largest markets for aesthetics combination therapy market. North America, the largest market by revenue, accounted for 37% value share in 2016; Persistence Market Research expects it to hold 41.3% revenue share by 2024. In terms of revenues, this will represent a US$ 1.52 billion opportunity. The U.S. will continue to dominate the North America aesthetics combination therapy market.

The aesthetics combination therapy market in Europe is anticipated to reach US$ 505.7 million by the end of 2017. Italy will continue to be the largest market for aesthetic combination therapy, closely followed by France. It is projected that the market in France will witness the second-highest CAGR during the forecast period.

Request Sample of This Report @ https://www.persistencemarketresearch.com/samples/10987

Persistence Market Research has profiled leading players in the global aesthetics combination therapy market. The key players include Alma Lasers Ltd., Lumenis Ltd., Cynosure Inc., Valeant Pharmaceutical International, Inc., Galderma S.A., Anika Therapeutics, Inc., Speciality European Pharma, Merz Pharma GmbH & Co. KGaA, Cutera Inc., Syneron Medical Ltd., and Allergan.
Currently, BTx-A/dermal filler is the sought-after therapy type, accounting for US$ 547.7 Mn in revenues in 2016. This segment is projected to grow at 10.9% CAGR through 2024. BTx-A/laser – the second largest segment in terms of revenues – is projected to grow at 6.6% CAGR.

To give readers a comprehensive analysis on the global aesthetics combination therapy market, Persistence Mar-ket Research has segmented the market by therapy, application, end-use, and region.

By therapy type, the key segments include,
• BTx-A/Dermal filler
• BTx-A/Laser
• Laser/Topical Drug
• Laser/Topical Drug
• Laser/Radiofrequency
• Dermal Filler/Topical Drug
• Others

Scar removal remains the largest application segment for aesthetic combination therapy market. Accounting for 28.2% revenue share of the market in 2016, this segment is projected to remain dominant during the period 2016-2024. Skin resurfacing is the second-largest segment in terms of revenue. Demand for aesthetics combination therapy is expected to witness strong growth in hair removal procedure. Tattoo removal remains the other key application segment.

Request For Methodology @ https://www.persistencemarketresearch.com/methodology/10987

By end-use, the global aesthetics combination therapy market has been segmented into hospitals, ambulatory sur-gical centers, and dermatology clinics. Dermatology clinics currently have a slight lead over hospitals and ambu-latory surgical centers in terms of revenue; however, during the period 2016-2024, this segment will extend its lead over ambulatory surgical centers and dermatology clinics. Dermatology clinics revenue is anticipated to grow at 10.7% CAGR.

Table of Contents

1. Executive Summary
2. Market Taxonomy
3. Global Hemoglobinopathy Market Analysis Scenario
3.1. Pricing Analysis
3.1.1. Pricing Assumptions

3.1.2. Price Analysis per Region
3.2. Market Size (US$ Mn) and Forecast
3.2.1. Market Size and Y-o-Y Growth
3.2.2. Absolute $ Opportunity
3.3. Market Overview
3.3.1. Global Hemoglobinopathy Market Reimbursement Scenario

4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side

4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Key Trends
4.6. Forecast Factors – Relevance and Impact

5. Global Hemoglobinopathy Market Analysis and Forecasts, by Indication
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis by Indication
5.3. Y-o-Y Growth Projections by Indication
5.4. Market Value Forecast, 2016–2024
5.4.1. Sickle Cell Disease
5.4.2. Beta Thalassemia
5.4.3. Alpha Thalassemia
5.5. Market Attractiveness by Indication

6. Global Hemoglobinopathy Market Analysis and Forecasts, by End User
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis by End User
6.3. Y-o-Y Growth Projections by End User

6.4. Market Value Forecast by End User, 2016–2024
6.4.1. Hospitals
6.4.2. Diagnostics Laboratories
6.4.3. Clinics
6.5. Market Attractiveness by End User

7. Global Hemoglobinopathy Market Analysis and Forecasts, by Test Type
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis by Test Type
7.3. Y-o-Y Growth Projections by Test Type
7.4. Market Value Forecast by Test Type, 2016–2024

7.4.1. Routine Red Blood Cell (RBC) Count
7.4.2. Genetic Testing
7.4.3. Hemoglobin by High Performance Liquid Chromatography
7.4.4. Hemoglobin Isoelectric Focusing (Hb IEF)
7.4.5. Hemoglobin electrophoresis (Hb ELP)
7.4.6. Hemoglobin Solubility Test
7.5. Market Attractiveness by Test Type

8. Global Hemoglobinopathy Market Analysis and Forecasts, by Region
8.1. Basis Point Share (BPS) Analysis by Country
8.2. Y-o-Y Growth Projections by Country
8.3. Market Value Forecast by Region
8.3.1. North America

8.3.2. Latin America
8.3.3. Europe
8.3.4. APAC
8.3.5. MEA
8.4. Market Attractiveness by Country

Buy Now @ https://www.persistencemarketresearch.com/checkout/10987

ABOUT US:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.